The c-Raf-1 protein kinase plays a central role in the mitogenic response of cells to growth factors, cytokines, and many oncogenes. Despite the critical importance of this enzyme, very little is known of its biochemical properties or mechanisms of regulation. In these experiments, we used the only candidate physiologic substrate identified as yet for c-Raf-1, mitogen-activated protein kinase kinase (MAPKK), to examine enzymatic characteristics and candidate modulators of c-Raf-1. c-Raf-1 was purified from Sf9 cells infected with recombinant baculovirus encoding a histidine-tagged c-Raf-1.
(1.5-fold). The increase is probably not of physiologic significance because it was about two orders of magnitude less than the stimulation of protein kinase C by these lipids. On gelfiltration chromatography, the peak of c-Raf-i kinase activity and immunoreactivt eluted at a predicted molecular mass of >150 kDa, suggesting that active c-Raf-i (but not inactive c-Raf-1) exists as a multimeric complex. This complex may not include p21m, however, because immunoreactive p2l1 was not identified in the active fractions.
c-Raf-1 is a ubiquitously expressed serine/threonine kinase that integrates mitogenic signals from a large number of growth factor receptors, cytokine receptors, several membrane-bound oncogenes (for review, see refs. 1 and 2), and some mitogenic peptides with G protein-linked receptors (3) . Despite the critical role c-Raf-1 plays in cellular response to mitogens, very little is known about its enzymatic characteristics or its regulation. Enzyme kinetic data have been limited largely because, until recently, physiological substrates of c-Raf-1 had not been identified. Assays have typically used immunoprecipitated protein, which is unsuitable for enzymatic analysis, along with nonphysiologic substrates that were phosphorylated at very low rates (4, 5) . Mechanisms of regulation have also been unclear. Because no kinase that activates c-Raf-1 has been identified and because although p21 binds to the N-terminal regulatory domain of c-Raf-1 (6, 7) , it has not been shown to activate c-Raf-1, another direct protein-protein interaction and, possibly, a lipid-protein interaction with the cysteine finger region of the regulatory domain may modulate c-Raf-1 (1, 2) . Recently, we and others (3, (8) (9) (10) have demonstrated that oncogenic variants of c-Raf-1 and mitogen-stimulated wildtype c-Raf-1 can phosphorylate and activate mitogenactivated protein kinase kinase (MAPKK) which, in turn, activates mitogen-activated protein kinase (MAPK) (11) (12) (13) . These results not only identified a physiologic substrate of c-Raf-1, MAPKK, allowing study of the enzyme characteristics of c-Raf-1 but also identified c-Raf-1 as the most proximal kinase in the critically important cascade of mitogen-stimulated kinases, which also includes p85rsk and the transcription factors p62TCF and c-Jun (14-16). Consequently, it is necessary to understand the enzymology and cellular mechanisms involved in regulating c-Raf-1 to understand transmission of the mitogenic signal in cells. We used MAPKK as substrate to characterize the biochemical properties of c-Raf-1.
MATERIALS AND METHODS

Materials.
[_32P]ATP was from DuPont-New England Nuclear. ATP (special quality) was from Boehringer Mannheim. Prostaglandins F2a (PGF2<,) and E2 (PGE2), 12- hydroxy-[S-(E,Z,Z,Z)]-5,8,10,14-eicosatetraenoic acid, and 14(15)-epoxyeicosatrienoic acid were from Cayman Chemicals (Ann Arbor, MI). Histones H1, H2A, H2B, H3, and H4 were from Boehringer Mannheim. Protein kinase C (PKC) and 1-acetyl-S-farnesylcysteine were from BioMol (Plymouth Meeting, PA). Genistein was from ICN. Microtubuleassociated protein 2 and 40S ribosomal subunits were prepared as described (17) (18) (19) . The Raf-1 autophosphorylation peptide (IVQQFGFQRRASDDGKLTD) and Kemptide (LR-RASLG) were from Peninsula Laboratories. Syntide 2 (PLARTLSVAGLPGKK) was provided by Edwin Krebs (University of Washington). Epidermal growth factor receptor T669 peptide (GVEPLTPSGEAPNQ) was synthesized by using described methods (20) . P81 phosphocellulose paper was from Whatman. Poly(vinylidene difluoride) membrane (Immobilon) was from Millipore. All other chemicals were from Sigma.
Expression and Purification of Histidine-Tagged c-Raf-i. Sf9 cells were infected with a baculovirus encoding histidine-tagged c-Raf-1 (six histidine residues added to the C terminus of the enzyme) alone or simultaneously infected with three separate baculoviruses containing histidine-tagged c-Raf-1, v-Src, and Val-12 v-Ras (21) at a multiplicity of infection of 10 using described methods (22) . Seventy-two hours after infection, Sf9 cells were lysed, as in ref. 23 , except that 0.4% Triton X-100 was included in the lysis buffer. Purification of the histidine-tagged protein was accomplished by loading the clarified extract onto a Ni2+-nitrilotriacetic acid-Sepharose column (Invitrogen) and eluting with imidazole-containing buffer (23) . c-Raf-1 was purified to a specific activity of 29,000 units/mg (where 1 unit = 1 pmol of phosphate transferred to MAPKK per min).
Purification of MAPKK. Bovine brain MAPKK was prepared as described (3) . Briefly, bovine brain was powdered, homogenized, and centrifuged (100,000 x g for 1.5 hr). The supernatant was equilibrated with DEAE-cellulose, and the breakthrough fraction was collected. The breakthrough fraction was subjected to Fast-S Sepharose chromatography. Fractions with peak activity were subjected to DEAECibachron blue-3GA agarose chromatography and finally concentrated with Mono S chromatography. This procedure routinely gave a preparation with a specific activity of 3500 units/mg (where 1 unit = 1 pmol of phosphate transferred to MAP kinase per min) with an overall recovery of 6%. On the basis of Coomassie blue staining (Fig. 1) , the preparation purity was =30% (3) . MAPKK concentration in the preparation was estimated by directly comparing intensity of the Coomassie blue-stained MAPKK band with dilutions of protein standards of known concentrations.
c-Raf-l Kinase Assays. c-Raf-1 kinase activity was assayed in MgCl2 (10 <10% of c-Raf-1 kinase activity. In assays examining potential lipid modulators of c-Raf-1, lipids were sonicated on ice in kinase assay buffer (50 mM (3-glycerol phosphate, pH = 7.3/1.5 mM EGTA/1 mM dithiothreitol/0.03% Brij 35) for 1 min before being added to the mixture. Sometimes (see Results), synthetic peptides were used as substrates. Afiquots of the reaction mixture were spotted onto P81 phosphocellulose paper and then immersed in a 5% trichloroacetic acid solution/10 mM phosphoric acid. Phosphocellulose papers were washed four times for 30 min, rinsed in acetone, dried, and subjected to liquid scintillation counting. Gel Filtration Chromatography. Purified histidine-tagged c-Raf-1 (200 1.l) was applied to a 1 x 30 cm Superose 12 column (Pharmacia) equilibrated with 20 mM Tris, pH 7.4/2 mM EGTA/200 mM NaCl/1 mM dithiothreitol/0.05% Triton X-100, and 0.5-ml fractions were collected. The column was calibrated before each analytic run with ferritin (440 kDa), catalase (232 kDa), aldolase (158 kDa) or IgG (150 kDa), bovine serum albumin (BSA, 67 kDa), and ovalbumin (43 kDa) or ribonuclease A (14 kDa). Xylene cyanol was used to indicate included volume.
Immunoblotting. Superose 12 column fractions were run on SDS/10% PAGE and then transferred to Immobilon. After blocking, the membranes were exposed to affinity-purified anti-Raf antiserum (anti-SP63), anti-Ras antiserum (Oncogene Science), or a monoclonal anti-GTPase-activating protein antibody (Upstate Biotechnology, Lake Placid, NY). Antibody binding was detected with the ECL immunoblotting system (Amersham).
RESULTS
Mg2+/Mn2+ Dependence. Dependence of c-Raf-1 kinase activity on Mg2+ and Mn2+ concentrations was determined ( Fig. 2 ). At 5 mM or less, the effect of the two cations on c-Raf-1 activity was equal, but at higher concentrations, c-Raf-1 kinase activity was =50% more with Mg2+ than with Mn2+. c-Raf-1 kinase activity was maximal at a Mg2+ concentration of 10 mM, and all subsequent kinase assays were done at 10 mM.
Modifiers of c-Raf-1 Kinase Activity. A number of potential modifiers of c-Raf-1 kinase activity were examined (Table 1) . c-Raf-1 activity was completely inhibited by Zn2+ and Co2+ (10 mM Enzyme Kinetics. The Km of c-Raf-1 for ATP was 11.6 ,uM (Fig. 3, Left) . The Km for MAPKK was 0.8 ,M (Fig. 3 (3, (8) (9) (10) . A number of nonphysiologic substrates have been used to examine c-Raf-1 kinase activity in immunoprecipitates from mitogenstimulated cells (4, 5, (24) (25) (26) (27) (28) (29) (30) Specifically, the basic substrates-histones H1, H2A, H2B, H3, and H4-were phosphorylated to levels 3-12% that of MAPKK. Other than MAPKK, myelin basic protein (250 ,ug/ml), a substrate of the MAP kinases, was the best of the substrates tested, but it was phosphorylated at only 22% the MAPKK rate (40 pg/ml). Microtubule-associated protein 2 was a poor substrate (9%o of MAPKK phosphorylation). Acidic substrates phosvitin and dephosphocasein were phosphorylated at 16 and 20o the MAPKK rate. Synthetic peptides, including Syntide 2 (4, 29) and the Raf-1 autophosphorylation peptide, a peptide with the sequence ofa putative c-Raf-1 pseudosubstrate or autophosphorylation site (5, 26), were very poor substrates. Phosphorylation of heatdenatured MAPKK (exposed to 550C for 5 min followed by centrifugation to remove any aggregates) was less than that of most other substrates tested. These data indicate that c-Raf-1 has an extremely restricted substrate specificity and that much of that specificity may be from tertiary-structural requirements.
Candidate Lipid Modulators. Analogous to PKC, the regulatory domain of c-Raf-1 contains a cysteine finger region that is predicted to bind to lipids (31) , suggesting that c-Raf-1 activity may, in part, be modulated by lipids (1, 40) . Because direct activation of c-Raf-1 by p2Vras has not yet been demonstrated, we examined whether lipids, some produced in response to mitogen stimulation of cells [arachidonic acid, diacylglycerol and its analog, 1-oleoyl-2-acetyl-sn-glycerol (OAG) phosphatidic acid, PGF2a, PGE2, 12-S-HETE, 14(15)-EpETrE; see Table 3 ], and others that are normal cellmembrane constituents [phosphatidylinositol 4,5-bisphosphate and phosphatidylserine (PtdSer)] modified c-Raf-1 kinase activity. We also examined whether an analog of farnesyl, 1-acetyl-S-farnesylcysteine, modified c-Raf-1 kinase activity because prenylation ofp21ras is critical for many of its biological functions (for review, see ref. 32 ), suggesting that the farnesyl group could play a role in c-Raf-1 activation. We examined the effects of these lipids, using both "active" c-Raf-1, derived from Sf9 cells simultaneously infected with recombinant baculoviruses encoding v-Ras, v-Src, and the histidine-tagged c-Raf-1, and "inactive" c-Raf-1, derived from Sf9 cells infected with the histidine-tagged c-Raf-1-encoding baculovirus only (Table 3) . None of the lipids significantly increased kinase activity of the "active" c-Raf-1. The combinations of Ca2+ (2.5 mM), PtdSer (100 AM), and either diacylglycerol (25 pg/ml) or OAG (10 ,ug/ml) increased kinase activity ofthe "inactive" c-Raf-1 by 1.5-fold (P < 0.05; Table 3 ). For comparison, in parallel assays, PtdSer with diacylglycerol or OAG increased the activity of PKC =110-fold over control. Gel-Filtration Chromatography. Analytic gel filtration with Superose 12 showed that the active enzyme eluted as a broad high molecular mass peak between ferritin (440 kDa) and IgG (150 kDa) (Fig. 4A) . Activity at the predicted molecular weight (coeluting with the 67-kDa BSA standard) was about half that of the peak fraction. The column fractions were also immunoblotted with affinity-purified anti-Raf-1 antibody (anti-SP63). Immunoreactive c-Raf-1 coeluted with MAPKKphosphorylating activity (Fig. 4A) . In contrast, the inactive enzyme eluted from the Superose 12 column at the predicted molecular mass, coeluting with BSA (Fig. 4B) . These data suggest that active c-Raf-1, but not inactive c-Raf-1, exists as a multimeric complex. Although recent evidence confirms that p21 binds to the regulatory domain of c-Raf-1 and, therefore, may modulate c-Raf-1 activity via a direct proteinprotein interaction (6, 7), p21ras (and p21ras-GTPaseactivating protein) was not identified in the active fractions by immunoblotting (data not shown).
DISCUSSION
In this report, we used the only known physiologic substrate of c-Raf-1, MAPKK, to characterize the enzyme kinetics and substrate specificity of c-Raf-1 and to explore modulation of kinase activity by several candidate modifiers. In contrast to prior reports (27) , we find that Mg2+ was preferred to Mn2+ at concentrations >5 mM. The Km of c-Raf-1 for ATP is 11.6 ,uM; this Km for ATP was determined at a MAPKK concentration just above the Km for MAPKK. The Km for ATP determined at higher concentrations of MAPKK could vary somewhat from this value. hybrid system (3, (7) (8) (9) (10) , that MAPKK is a physiologic substrate of c-Raf-1.
c-Raf-1 substrate specificity is extremely restricted. Fifteen other potential substrates were examined. Some of these, notably histones, Syntide 2, and the Raf-1 autophosphorylation peptide, had been used to examine mitogeninduced activation ofc-Raf-1 in prior studies (4, 5, (24) (25) (26) (27) (28) (29) (30) . All model substrates were phosphorylated at markedly slower rates than MAPKK (<22%), despite being at concentrations 6-to 7-fold higher than that of MAPKK. This restricted substrate specificity demands that future studies of c-Raf-1 activation not use artificial substrates unless they have been shown equivalent in affinity to MAPKK.
Heat denaturation of MAPKK dramatically reduced its phosphorylation by c-Raf-1. This observation indicates that the restricted substrate specificity of c-Raf-1 may be due, in large part, to a requirement for specific tertiary-structural features of the substrate. Heat denaturation of MAPKK may eliminate tertiary-structural determinants for c-Raf-1 phosphorylation, leaving only a primary sequence determinant and thereby reduce MAPKK phosphorylation to levels observed for model substrates. The MAP kinases, in addition to a proline-directed substrate specificity, have also been shown to act optimally when substrates possess important tertiarystructure requirements. For example, c-Jun, but not v-Jun (which lacks an N-terminal delta domain), is a MAP kinase substrate, even though both c-Jun and v-Jun contain the N-terminal phosphorylation sites (33) .
The restricted substrate specificity of c-Raf-1 is in distinct contrast to the more "downstream" kinases in the cascade, the MAP kinases, which phosphorylate and activate a number of substrates (e.g., S6 kinase, c-Jun, p62TCF, and phospholipase A2) (14-16, 34, 35) . Although other physiologic substrates of c-Raf-1 may be found, the restricted substrate specificity of c-Raf-1, with only one physiologic substrate identified to date, may create a "checkpoint" at c-Raf-1/ MAPKK through which mitogenic signals, originating from a number of widely divergent sources, must pass.
Bruder et al. (31) have compared the amino acid sequence of the cysteine finger region of the regulatory domain of c-Raf-1 to that of several transcription factors and isoforms of PKC and have suggested that the c-Raf-1 cysteine finger is more likely a lipid-binding than a DNA-binding region. Because no c-Raf-1 kinase kinase that activates c-Raf-1 has been identified, and p2lras binds to the regulatory domain of c-Raf-1 (6, 7) but has not been demonstrated to activate c-Raf-1, another direct protein-protein or lipid-protein interaction with the regulatory domain may modulate c-Raf-1 activity (1, 2, 40) . We examined c-Raf-1 activity in the presence of normal cell-membrane lipid components, several lipids and representatives of three classes of eicosanoids that are produced in response to mitogens, and an analog of farnesyl. Only the combination of Ca2+, PtdSer, and diacylglycerol or OAG produced a significant increase (1.5-fold) in c-Raf-1 kinase activity. The increase is unlikely to be of physiologic significance, however, because the activation does not approach the magnitude of activation of c-Raf-1 after mitogen stimulation in situ (4-to 20-fold) (3). By comparison, the same combinations of lipids increased PKC activity 110-fold. Phosphatidylinositol trisphosphate, produced by the phosphatidylinositol 3-kinase in response to many of the growth factors that activate c-Raf-1, also fails to increase c-Raf-1 kinase activity in vitro under conditions that strQngly activate PKC C(J. Exton, personal communication).
Many potential lipid modulators were not tested for their ability to activate c-Raf-1, and a c-Raf-1-lipid interaction could be very specific to one particular lipid. To date, however, lipid activation of protein kinases or phosphatases has been an effect common to a class or group of lipids (36) (37) (38) . Although these lipids when tested alone were insufficient to activate c-Raf-1, this does not rule out a role for these or other lipids, in conjunction with cofactors, such as p2lras (6, 7, (39) (40) (41) , in c-Raf-1 modulation or a role in localizing c-Raf-1 to membranes.
Results from gel-filtration chromatography suggest that active c-Raf-1 from Sf9 cells triply infected with baculoviruses carrying c-raf-1, v-src, and v-ras, but not inactive c-Raf-1 from cells infected only with the c-raf-l baculovirus, exists, in large part, as a multimeric protein or aggregate and that this multimeric structure survives the relatively harsh elution from the Ni2+ column. The absence of lipid modulation and the evidence for a multimeric complex containing active c-Raf-1 support the contention that protein-protein interactions rather than lipid-protein interactions may be responsible for modulation of c-Raf-1 kinase activity. The identity of the other proteins in this multimeric complex and their relevance to c-Raf-1 activation is unknown. Recent data suggest that a protein-protein interaction between p2lras and the cysteine finger-containing regulatory domain of c-Raf-1 may directly modulate c-Raf-1 kinase (6, 7). The absence of p2lras in the active column fractions suggests that if the p21ras-c-Raf-1 interaction is necessary for initial activation, it may not be necessary to maintain the kinase in an active state. Alternatively, because the stoichiometry of p21ras-Raf binding may be relatively low (6) , the amount of p2lras in the active fractions may have been below detection.
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